MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis
Public ClinicalTrials.gov record NCT01497223. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Fluconazole Versus Fluconazole And MGCD290 for the Treatment of Moderate to Severe Vulvovaginal Candidiasis
Study identification
- NCT ID
- NCT01497223
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- MethylGene Inc.
- Industry
- Enrollment
- 220 participants
Conditions and interventions
Conditions
Interventions
- MGCD290 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2011
- Primary completion
- Mar 31, 2013
- Completion
- Mar 31, 2013
- Last update posted
- Apr 3, 2013
2011 – 2013
United States locations
- U.S. sites
- 19
- U.S. states
- 15
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Women's Health Care Research Corp. | San Diego | California | 92123 | — |
| Altus Research | Lake Worth | Florida | 33461 | — |
| Healthcare Clinical Data, Inc. | North Miami | Florida | 33161 | — |
| Georgia Health Sciences University | Augusta | Georgia | 30912-3500 | — |
| Clinical Trials Management | Covington | Louisiana | 70433 | — |
| Clinical Trials Management, LLC | Metairie | Louisiana | 70006 | — |
| Harper University Hospital | Detroit | Michigan | 48201 | — |
| Clinical Research of Nevada | Las Vegas | Nevada | 89123 | — |
| SUNY Downstate Medical Center | Brooklyn | New York | 11203 | — |
| Lyndhurst Clinical Research | Raleigh | North Carolina | 27607 | — |
| Lyndhurst Clinical Research | Winston-Salem | North Carolina | 27103 | — |
| Drexel University College of Medicine | Philadelphia | Pennsylvania | 19102 | — |
| Magee-Womens Hospital of UPMC | Pittsburgh | Pennsylvania | 15213 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29403 | — |
| Brownstone Clinical Trials | Irving | Texas | 75061 | — |
| Physician's Research Options | Sandy City | Utah | 84070 | — |
| Tidewater Physicians for Women | Norfolk | Virginia | 23502 | — |
| University of Washington | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01497223, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 3, 2013 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01497223 live on ClinicalTrials.gov.